1. Merck Patent Gmbh (31 from 2,945 patents)

2. Athersys, Inc. (4 from 32 patents)

3. Abt Holding Company (1 from 35 patents)

1. 11491153 - Methods for treating cancer using pyrimidine and pyridine compounds with BTK inhibitory activity

2. 10287300 - Heterocyclic derivatives as modulators of kinase activity

3. 10233160 - Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors

4. 10087166 - Cyclic amine azaheterocyclic carboxamides

5. 10080750 - Aminopyrimidine derivatives for use as modulators of kinase activity

6. 10080753 - Heterocyclic carboxamides as modulators of kinase activity

7. 9980966 - Combinations of cancer therapeutics

8. 9981925 - Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors

9. 9938268 - C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof

10. 9867826 - Heterocycles as modulators of kinase activity

11. 9850255 - Heterocyclic derivatives as modulators of kinase activity

12. 9662330 - Aminopyrimidine derivatives for use as modulators of kinase activity

13. 9586938 - Cyclic amine azaheterocyclic carboxamides

14. 9580443 - Heterocyclic derivatives as modulators of kinase activity

15. 9458134 - Heterocycles as modulators of kinase activity